Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
OPTI.L Stock Summary
In the News
OPTI.L Financial details
Company Rating
Sell
Market Cap
21.66M
Income
-7.27M
Revenue
1.94M
Book val./share
0.1
Cash/share
0.01
Dividend
-
Dividend %
-
Employees
9
Optionable
No
Shortable
Yes
Earnings
26 Jun 2024
P/E
8.61
Forward P/E
-
PEG
-0.4
P/S
52.83
P/B
2.04
P/C
1960
P/FCF
-18.91
Quick Ratio
3.78
Current Ratio
6.68
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0.08
EPS next Y
-
EPS next Q
-
EPS this Y
-59.02%
EPS next Y
-
EPS next 5Y
-227.68%
EPS last 5Y
NAN%
Revenue last 5Y
-2.33%
Revenue Q/Q
3.81%
EPS Q/Q
-82.58%
-
-
-
-
SMA20
-12%
SMA50
-15.38%
SMA100
-29.03%
Inst Own
-
Inst Trans
-
ROA
22%
ROE
18%
ROC
-0.22%
Gross Margin
53%
Oper. Margin
-544%
Profit Margin
566%
Payout
-
Shs Outstand
91.19M
Shs Float
74.29M
-
-
-
-
Target Price
-
52W Range
5.57-43.495
52W High
-54.42%
52W Low
+292%
RSI
29
Rel Volume
2.51
Avg Volume
228.39K
Volume
572.43K
Perf Week
-20%
Perf Month
-16.6%
Perf Quarter
-20.81%
Perf Half Y
-25.76%
-
-
-
-
Beta
1.615
-
-
Volatility
1.77%, 2.08%
Prev Close
0%
Price
19.6
Change
-8.84%
OPTI.L Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-11-30 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.01 | 0.01 | 0.02 | 0.02 | 0 | |
Net income per share | -0.02 | -0.03 | 0.06 | 0.07 | 0.03 | |
Operating cash flow per share | -0.02 | -0.02 | -0.01 | -0.02 | -0.01 | |
Free cash flow per share | -0.02 | -0.03 | -0.01 | -0.02 | -0.01 | |
Cash per share | 0.02 | 0.01 | 0.01 | 0.02 | 0.01 | |
Book value per share | 0.09 | 0.06 | 0.12 | 0.19 | 0.12 | |
Tangible book value per share | 0.06 | 0.03 | 0.1 | 0.16 | 0.1 | |
Share holders equity per share | 0.09 | 0.06 | 0.12 | 0.19 | 0.12 | |
Interest debt per share | 0 | 0.01 | 0.01 | 0.01 | -0.05 | |
Market cap | 76.89M | 56.27M | 55.43M | 43.95M | 12.33M | |
Enterprise value | 75.56M | 56.54M | 55.34M | 42.76M | 11.28M | |
P/E ratio | -40.06 | -23.76 | 9.55 | 7.02 | 4.77 | |
Price to sales ratio | 149.5 | 75.55 | 36.39 | 19.86 | 26.98 | |
POCF ratio | -62.33 | -32.66 | -59.73 | -28.09 | -11.12 | |
PFCF ratio | -62.18 | -24.27 | -43.36 | -25 | -9.66 | |
P/B Ratio | 10.94 | 11.38 | 4.69 | 2.42 | 1.13 | |
PTB ratio | 10.94 | 11.38 | 4.69 | 2.42 | 1.13 | |
EV to sales | 146.93 | 75.91 | 36.33 | 19.32 | 24.68 | |
Enterprise value over EBITDA | -55.69 | -29.02 | -47.42 | -39.71 | -4.8 | |
EV to operating cash flow | -61.26 | -32.81 | -59.63 | -27.33 | -10.17 | |
EV to free cash flow | -61.11 | -24.39 | -43.29 | -24.32 | -8.83 | |
Earnings yield | -0.02 | -0.04 | 0.1 | 0.14 | 0.21 | |
Free cash flow yield | -0.02 | -0.04 | -0.02 | -0.04 | -0.1 | |
Debt to equity | 0 | 0.15 | 0.07 | 0.05 | 0 | |
Debt to assets | 0 | 0.11 | 0.06 | 0.04 | 0 | |
Net debt to EBITDA | 0.98 | -0.14 | 0.08 | 1.1 | 0.45 | |
Current ratio | 3.9 | 2.34 | 3.86 | 6.41 | 6.68 | |
Interest coverage | 0 | -48.72 | -24.72 | -28.68 | 0.5 | |
Income quality | 0.64 | 0.73 | 0.83 | 1.15 | 0.45 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 3.23 | 2.67 | 0.48 | 0.42 | 1.82 | |
Research and developement to revenue | 0.31 | 0.23 | 0.06 | 0.03 | 0.15 | |
Intangibles to total assets | 0.28 | 0.39 | 0.2 | 0.13 | 0.13 | |
Capex to operating cash flow | 0 | 0.35 | 0.38 | 0.12 | 0.15 | |
Capex to revenue | -0.01 | -0.8 | -0.23 | -0.09 | -0.37 | |
Capex to depreciation | -0.02 | -2.73 | -1.41 | -0.67 | -0.75 | |
Stock based compensation to revenue | 0.25 | 0.17 | 0.08 | 0.03 | 0.02 | |
Graham number | 0.21 | 0.19 | 0.41 | 0.53 | 0.27 | |
ROIC | -0.22 | -0.36 | -0.09 | -0.07 | -0.24 | |
Return on tangible assets | -0.33 | -0.57 | 0.53 | 0.36 | 0.26 | |
Graham Net | 0.01 | -0.01 | 0 | 0.01 | 0.01 | |
Working capital | 1.51M | 754.49K | 1.49M | 3.25M | 1.58M | |
Tangible asset value | 4.81M | 2.35M | 9.12M | 15.53M | 9.37M | |
Net current asset value | 1.07M | -494.67K | 152.9K | 1.88M | 1.21M | |
Invested capital | 0 | 0.15 | 0.07 | 0.05 | 0 | |
Average receivables | 124.54K | 513.28K | 877K | 1.35M | 1.19M | |
Average payables | 62.92K | 231.76K | 353.57K | 391.13K | 306.97K | |
Average inventory | 19.66K | 46.6K | 123.5K | 143.06K | 139.94K | |
Days sales outstanding | 162.4 | 390.9 | 229.14 | 287.61 | 500.78 | |
Days payables outstanding | 259.42 | 222.7 | 203.83 | 141.68 | 327.3 | |
Days of inventory on hand | 68.24 | 40.18 | 104.51 | 34.13 | 305.02 | |
Receivables turnover | 2.25 | 0.93 | 1.59 | 1.27 | 0.73 | |
Payables turnover | 1.41 | 1.64 | 1.79 | 2.58 | 1.12 | |
Inventory turnover | 5.35 | 9.08 | 3.49 | 10.7 | 1.2 | |
ROE | -0.27 | -0.48 | 0.49 | 0.35 | 0.24 | |
Capex per share | 0 | -0.01 | 0 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-06-30 for Q2
Metric | History | 2021-06-30 | 2021-12-31 | 2022-06-30 | 2022-12-31 | 2023-06-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.01 | 0.01 | 0 | 0 | 0 | |
Net income per share | 0.16 | -0.09 | 0.15 | -0.12 | -0.02 | |
Operating cash flow per share | -0.01 | -0.01 | 0 | -0.01 | -0.01 | |
Free cash flow per share | -0.01 | -0.01 | 0 | -0.01 | -0.01 | |
Cash per share | 0.01 | 0.02 | 0.02 | 0.01 | 0.01 | |
Book value per share | 0.3 | 0.21 | 0.23 | 0.12 | 0.1 | |
Tangible book value per share | 0.27 | 0.18 | 0.2 | 0.1 | 0.09 | |
Share holders equity per share | 0.3 | 0.21 | 0.23 | 0.12 | 0.1 | |
Interest debt per share | 0.01 | 0.01 | 0 | 0 | 0 | |
Market cap | 43.53M | 40.12M | 19.52M | 12.08M | 7.28M | |
Enterprise value | 43.34M | 38.93M | 18.01M | 11.03M | 6.39M | |
P/E ratio | 0.76 | -1.25 | 0.35 | -0.27 | -0.99 | |
Price to sales ratio | 40.45 | 35.29 | 164.19 | 35.74 | 20.75 | |
POCF ratio | -68.21 | -43.3 | -47.14 | -17.39 | -12.43 | |
PFCF ratio | -56.34 | -40.7 | -41.37 | -15.01 | -12.12 | |
P/B Ratio | 1.67 | 2.21 | 0.9 | 1.11 | 0.8 | |
PTB ratio | 1.67 | 2.21 | 0.9 | 1.11 | 0.8 | |
EV to sales | 40.28 | 34.24 | 151.5 | 32.63 | 18.21 | |
Enterprise value over EBITDA | -95.86 | -62.31 | -19.38 | -8.26 | -9.58 | |
EV to operating cash flow | -67.91 | -42.02 | -43.49 | -15.88 | -10.9 | |
EV to free cash flow | -56.1 | -39.5 | -38.17 | -13.7 | -10.63 | |
Earnings yield | 0.33 | -0.2 | 0.71 | -0.94 | -0.25 | |
Free cash flow yield | -0.02 | -0.02 | -0.02 | -0.07 | -0.08 | |
Debt to equity | 0.03 | 0.05 | 0 | 0 | 0 | |
Debt to assets | 0.03 | 0.04 | 0 | 0 | 0 | |
Net debt to EBITDA | 0.42 | 1.9 | 1.62 | 0.79 | 1.34 | |
Current ratio | 3.86 | 6.41 | 8.39 | 6.68 | 3.59 | |
Interest coverage | -25.74 | -31.64 | 0 | 0 | 0 | |
Income quality | -0.04 | 0.12 | -0.03 | 0.06 | 0.32 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.86 | 1.08 | 8.33 | 4.24 | 2.35 | |
Research and developement to revenue | 0 | 0.06 | 0 | 0.2 | 0 | |
Intangibles to total assets | 0.1 | 0.13 | 0.1 | 0.13 | 0.15 | |
Capex to operating cash flow | 0.21 | 0.06 | 0.14 | 0.16 | 0.03 | |
Capex to revenue | -0.12 | -0.05 | -0.49 | -0.33 | -0.04 | |
Capex to depreciation | -0.93 | -0.41 | -0.49 | -1.03 | -0.16 | |
Stock based compensation to revenue | 0.03 | 0.03 | 0.05 | 0.02 | 0 | |
Graham number | 1.04 | 0.66 | 0.87 | 0.58 | 0.22 | |
ROIC | -0.02 | -0.04 | -0.05 | -0.13 | -0.08 | |
Return on tangible assets | 0.56 | -0.46 | 0.69 | -1.13 | -0.22 | |
Graham Net | 0 | 0.02 | 0.01 | 0.01 | 0.01 | |
Working capital | 1.84M | 3.25M | 1.88M | 1.58M | 1.33M | |
Tangible asset value | 23.42M | 15.53M | 19.52M | 9.37M | 7.6M | |
Net current asset value | 475.92K | 1.88M | 1.42M | 1.21M | 982K | |
Invested capital | 0.03 | 0.05 | 0 | 0 | 0 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 0 | 0 | 0 | 0 | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 117.22 | 138.04 | 380.28 | 166.9 | 197.95 | |
Days payables outstanding | 77.59 | 60.27 | 131.82 | 65.39 | 161.75 | |
Days of inventory on hand | 10.41 | 14.52 | 66 | 60.94 | 56.33 | |
Receivables turnover | 0.77 | 0.65 | 0.24 | 0.54 | 0.45 | |
Payables turnover | 1.16 | 1.49 | 0.68 | 1.38 | 0.56 | |
Inventory turnover | 8.65 | 6.2 | 1.36 | 1.48 | 1.6 | |
ROE | 0.55 | -0.44 | 0.64 | -1.04 | -0.2 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
OPTI.L Frequently Asked Questions
What is OptiBiotix Health Plc stock symbol ?
OptiBiotix Health Plc is a GB stock and trading under the symbol OPTI.L
What is OptiBiotix Health Plc stock quote today ?
OptiBiotix Health Plc stock price is $19.6 today.
Is OptiBiotix Health Plc stock public?
Yes, OptiBiotix Health Plc is a publicly traded company.